Name | 4-{[(2R,4S)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid |
---|---|
Synonyms |
4-{[(2R,4S)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid
[1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, α-ethyl ester, (αS,γR)- 4-(((2R,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid LCZ696 impurity 18 (alphaS,gammaR)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester 2R,4S-Sacubitril |
Description | 2R,4S-Sacubitril is the impurity of Sacubitril. Sacubitril is approved by the Food and Drug Administration for use in combination with valsartan for the treatment of patients with heart failure. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 656.9±55.0 °C at 760 mmHg |
Molecular Formula | C24H29NO5 |
Molecular Weight | 411.491 |
Flash Point | 351.1±31.5 °C |
Exact Mass | 411.204559 |
LogP | 3.96 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.549 |
Storage condition | 2-8℃ |